Opportunity Information: Apply for RFA CA 13 012
Apply for RFA CA 13 012
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NCI Community Oncology Research Program (NCORP) Research Bases (UM1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.399 Cancer Control.
- This funding opportunity was created on Nov 8, 2013 and posted on Nov 8, 2013.
- Applicants must submit their applications by Jan 8, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) Applicant institutions must be appropriate leading institutions with comprehensive expertise in cancer clinical trials, such as institutions that are cancer foundations, healthcare research organizations (including sites of Clinical Trials Cooperative Groups or NCTN Group Operations Centers), NCI designated Cancer Centers, or integrated healthcare systems. Applicant institutions must have an established organizational structure for the design and conduct of multi center cancer prevention, control and screening/post treatment surveillance clinical trials and cancer care delivery research. Institutions that are clinical sites for the NCI Clinical Trials Cooperative Groups or are applicants for the NCTN Lead Academic Site award (or awardees of that NCTN component). Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NCI Community Oncology Research Program (NCORP) Research Bases (UM1) funding opportunity (RFA-CA-13-012) is a National Institutes of Health (NIH), National Cancer Institute (NCI) cooperative agreement intended to support a set of centralized "Research Bases" that help run NCORP as a single, coordinated, community-based national research network. NCORP was created to unify and build on earlier NCI-supported community programs, including the Community Clinical Oncology Program (CCOP), Minority-Based CCOPs, CCOP Research Bases, and the NCI Community Cancer Centers Program (NCCCP). In practical terms, the FOA is looking for experienced lead institutions that can serve as hubs for developing studies and coordinating multicenter research that takes place largely in community settings, where many patients actually receive their cancer care.
The core purpose of these NCORP Research Bases is to design and conduct clinical trials and research that focus on cancer prevention, cancer control, screening, and post-treatment surveillance, as well as cancer care delivery research (how care is organized, financed, delivered, and improved in real-world settings). Another major aim is to expand access for patients and providers in the community to take part in treatment and imaging clinical trials that are run through the reorganized National Clinical Trials Network (NCTN). Embedded throughout the program is an explicit priority to integrate cancer disparities questions into both clinical trials and cancer care delivery research, meaning the network is expected to help generate evidence that is relevant to underserved populations and to address inequities in outcomes, access, and quality of care.
This award uses the UM1 mechanism, which is a cooperative agreement. That matters because it signals substantial NIH/NCI scientific or programmatic involvement during the life of the award, rather than a purely investigator-initiated grant where the federal role is more hands-off. The funding instrument reflects the networked nature of NCORP and the expectation that awardees will collaborate closely with NCI and other components of the national clinical trials infrastructure to prioritize studies, maintain consistent operations, and ensure high-quality multicenter execution.
Eligible applicants are broadly defined across U.S.-based organizations, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit organizations (other than small businesses), special district governments, and federally recognized tribal governments, among others. The eligibility language also explicitly includes many mission-focused institution types and community-serving entities such as HBCUs, Hispanic-serving institutions, AANAPISIs, tribally controlled colleges and universities, faith-based or community-based organizations, and regional organizations, provided they meet the programmatic expectations. At the same time, the FOA is clear that applicant institutions must be appropriate leading institutions with comprehensive expertise in cancer clinical trials and have an established organizational structure capable of designing and conducting multicenter cancer prevention/control/surveillance trials and cancer care delivery research. Examples given include cancer foundations, healthcare research organizations (including sites tied to Clinical Trials Cooperative Groups or NCTN Group Operations Centers), NCI-designated Cancer Centers, and integrated healthcare systems. Non-U.S. entities are not eligible, and foreign components are not allowed under NIH policy.
From an administrative standpoint, there is no cost sharing or matching requirement. The opportunity was posted and created on November 8, 2013, with an original and current closing date of January 8, 2014, and an archive date of February 8, 2014. The activity areas align with multiple cancer-related CFDA listings (93.393, 93.394, 93.395, and 93.399), reflecting the broad scope spanning cause and prevention, detection and diagnosis, treatment, and cancer control. The full announcement is available through the NIH Grants Guide at http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-012.html, and NIH provides an OER webmaster contact for access or linking issues.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is the NCI Community Oncology Research Program (NCORP) Research Bases (UM1) cooperative agreement, referenced as RFA-CA-13-012. It is sponsored by the National Institutes of Health (NIH), National Cancer Institute (NCI).
What is being funded under this FOA?
The FOA funds a set of centralized "Research Bases" that function as hubs to help run NCORP as a single, coordinated, community-based national research network. These Research Bases develop studies and coordinate multicenter research conducted largely in community settings where many patients receive cancer care.
What is the core purpose of NCORP Research Bases?
The core purpose is to design and conduct clinical trials and research focused on cancer prevention, cancer control, screening, and post-treatment surveillance, as well as cancer care delivery research (how cancer care is organized, financed, delivered, and improved in real-world settings).
Does this program involve treatment or imaging clinical trials?
Yes. A major aim is to expand access for community patients and providers to participate in treatment and imaging clinical trials run through the reorganized National Clinical Trials Network (NCTN).
What is cancer care delivery research in the context of this FOA?
In this FOA, cancer care delivery research refers to research on how cancer care is organized, financed, delivered, and improved in real-world community settings.
How does the FOA address cancer disparities?
The FOA includes an explicit priority to integrate cancer disparities questions into both clinical trials and cancer care delivery research, with the expectation that the network will generate evidence relevant to underserved populations and help address inequities in outcomes, access, and quality of care.
What does it mean that the award uses a UM1 mechanism?
UM1 is a cooperative agreement mechanism. It indicates substantial NIH/NCI scientific or programmatic involvement during the life of the award, reflecting the networked nature of NCORP and the expectation of close collaboration with NCI and the national clinical trials infrastructure.
How is a cooperative agreement different from a typical research grant?
Based on the FOA description, the key distinction is that a cooperative agreement involves substantial NIH/NCI involvement during the award period, rather than a more hands-off approach typical of purely investigator-initiated grants.
What kinds of institutions are eligible to apply?
Eligible applicants include a wide range of U.S.-based organizations such as public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit organizations (other than small businesses), special district governments, and federally recognized tribal governments, among others.
Are community-serving institutions explicitly included in the eligibility language?
Yes. The eligibility language explicitly includes institution types and entities such as HBCUs, Hispanic-serving institutions, AANAPISIs, tribally controlled colleges and universities, faith-based or community-based organizations, and regional organizations, provided they meet the programmatic expectations.
Are there specific expectations for the lead applicant institution?
Yes. The FOA states that applicant institutions must be appropriate leading institutions with comprehensive expertise in cancer clinical trials and have an established organizational structure capable of designing and conducting multicenter cancer prevention/control/surveillance trials and cancer care delivery research.
What examples of appropriate lead institutions are mentioned?
Examples provided include cancer foundations, healthcare research organizations (including sites tied to Clinical Trials Cooperative Groups or NCTN Group Operations Centers), NCI-designated Cancer Centers, and integrated healthcare systems.
Are non-U.S. entities eligible to apply?
No. Non-U.S. entities are not eligible.
Are foreign components allowed?
No. Foreign components are not allowed under NIH policy, as stated in the opportunity description.
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
When was this opportunity posted?
The opportunity was posted and created on November 8, 2013.
What are the closing dates for this opportunity?
The original and current closing date listed is January 8, 2014.
When was the opportunity archived?
The archive date listed is February 8, 2014.
What is NCORP and how does it relate to prior NCI programs?
NCORP was created to unify and build on earlier NCI-supported community programs, including the Community Clinical Oncology Program (CCOP), Minority-Based CCOPs, CCOP Research Bases, and the NCI Community Cancer Centers Program (NCCCP).
What is the role of Research Bases within NCORP operations?
Research Bases support NCORP as a single coordinated network by acting as centralized hubs that develop studies, coordinate multicenter research, and work with NCI and other parts of the national clinical trials infrastructure to prioritize studies, maintain consistent operations, and support high-quality multicenter execution.
What activity areas or CFDA listings are associated with this program?
The activity areas align with multiple cancer-related CFDA listings: 93.393, 93.394, 93.395, and 93.399, spanning cancer causes and prevention, detection and diagnosis, treatment, and cancer control.
Where can the full announcement be found?
The full announcement is available through the NIH Grants Guide at http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-012.html.
Who should be contacted for access or linking issues related to the announcement?
NIH provides an Office of Extramural Research (OER) webmaster contact for access or linking issues.
What is the overall emphasis of the research environment supported by this FOA?
The FOA emphasizes community-based, multicenter research carried out in real-world settings, with centralized Research Bases coordinating study development and execution across the network.
Browse more opportunities from the same category: Education Health
Next opportunity: NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1)
Previous opportunity: NCI Community Oncology Research Program(NCORP) Community Sites (UM1)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 13 012
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 13 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1) Apply for RFA CA 13 014 Funding Number: RFA CA 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA MH 14 214 Funding Number: RFA MH 14 214 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Indo US Collaborative Program on Affordable Medical Devices (R03) Apply for PAR 13 390 Funding Number: PAR 13 390 Agency: National Institutes of Health Category: Education Health Funding Amount: $75,000 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007 Funding Number: PAR 14 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Identification of Gene Variants for Addiction Related Traits by Next Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) Apply for PAR 14 010 Funding Number: PAR 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| The Palliative Care Research Cooperative (PCRC) Enhancing Sustainability and Building the Science of Palliative Care (R01) Apply for RFA NR 14 003 Funding Number: RFA NR 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Revision Applications for Research on Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 012 Funding Number: PAR 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 011 Funding Number: PAR 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R01) Apply for PA 14 014 Funding Number: PA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21) Apply for PA 14 013 Funding Number: PA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Public Health Impact of the Changing Policy/Legal Environment for Marijuana (R01) Apply for PAS 14 020 Funding Number: PAS 14 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Discovering Novel Targets The Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 14 025 Funding Number: PA 14 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Mechanisms of Brain Development for Substance Use and Dependence (R01) Apply for PA 14 026 Funding Number: PA 14 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 14 031 Funding Number: PAR 14 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R01) Apply for PA 14 029 Funding Number: PA 14 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Chronic Illness Self Management in Children and Adolescents (R21) Apply for PA 14 030 Funding Number: PA 14 030 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R21) Apply for PA 14 034 Funding Number: PA 14 034 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Reducing Health Disparities Among Minority and Underserved Children (R01) Apply for PA 14 033 Funding Number: PA 14 033 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 14 036 Funding Number: PA 14 036 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Women Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 14 037 Funding Number: PA 14 037 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 13 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.